Senior GTN & Cost Accounting Leader — Equity + Bonus

SolomonEdwards; United States; On-site; USD 150,000 - 190,000; Full time

Benefits offered by this job

Equity participation

Comprehensive benefits

Bonus potential

Job summary

SolomonEdwards is seeking a Manager or Senior Manager for Gross-to-Net & Cost Accounting in the Greater Philadelphia Area. The role focuses on GTN revenue accounting, inventory valuation, COGS, and financial controls while partnering with commercial and finance leadership. Equity and a 15% bonus accompany a 150k–190k salary range.

Ideal candidates have 5–8+ years in pharma/biotech accounting, strong GAAP knowledge, and a track record building scalable processes ahead of commercial expansion.

Qualifications

• 5–8+ years of progressive accounting experience in life sciences preferred.
• Strong GTN, cost and inventory accounting experience.
• Solid understanding of U.S. GAAP, ASC 606 and SOX controls.

Responsibilities

• Develop and implement GTN revenue estimation models and reserves.
• Oversee rebates, chargebacks, distributions, prompt-pay discounts, and returns.
• Partner with commercial, market access, and finance teams on contracts.
• Manage monthly GTN reserves, reconciliations, and variance analysis.
• Maintain revenue recognition policies under ASC 606.
• Establish standard costing, inventory valuation, and COGS accounting.
• Collaborate with supply chain and logistics for costs.
• Support SOX controls, audits, and documentation.

Skills

GTN revenue accounting

Cost accounting

Inventory accounting

U.S. GAAP

ASC 606

SOX compliance

Education

Bachelor's degree in Accounting, Finance, or related field

Job description

SolomonEdwards is seeking a Manager or Senior Manager for Gross-to-Net & Cost Accounting in the Greater Philadelphia Area. The role focuses on GTN revenue accounting, inventory valuation, COGS, and financial controls while partnering with commercial and finance leadership. Equity and a 15% bonus accompany a 150k–190k salary range.

Ideal candidates have 5–8+ years in pharma/biotech accounting, strong GAAP knowledge, and a track record building scalable processes ahead of commercial expansion.